<p>The World Health Organization on Tuesday said a decision on the Emergency Use Listing (EUL) Covaxin will be finalised next week after an assessment of the risks and benefits of the vaccine.</p>.<p>"WHO & an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin," the World Health Organization said on Twitter.</p>.<p>It said that the Hyderabad-based Bharat Biotech, which manufactures Covaxin, had submitted additional information at the request of the health body on September 27, which was currently being reviewed.</p>.<p>"Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling basis & submitted additional info at WHO’s request on 27 September. WHO experts are currently reviewing this info & if it addresses all questions raised, WHO assessment will be finalized next week," it said.</p>.<p>The health body had earlier said that a decision on Bharat Biotech’s submission seeking emergency use listing (EUL) for Covaxin <a href="https://www.deccanherald.com/national/decision-on-bharat-biotechs-covaxin-eul-in-october-who-1035759.html" target="_blank">will be made in October</a>.</p>.<p>Bharat Biotech is yet to publish the results of phase 3 trials of the indigenously developed Covaxin, which is being administered as part of the country's immunisation drive against Covid-19.</p>.<p>WHO approval is crucial for allowing those who have been administered the vaccine to undertake foreign travel.</p>.<p><strong>Watch latest videos by DH here:</strong></p>
<p>The World Health Organization on Tuesday said a decision on the Emergency Use Listing (EUL) Covaxin will be finalised next week after an assessment of the risks and benefits of the vaccine.</p>.<p>"WHO & an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin," the World Health Organization said on Twitter.</p>.<p>It said that the Hyderabad-based Bharat Biotech, which manufactures Covaxin, had submitted additional information at the request of the health body on September 27, which was currently being reviewed.</p>.<p>"Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling basis & submitted additional info at WHO’s request on 27 September. WHO experts are currently reviewing this info & if it addresses all questions raised, WHO assessment will be finalized next week," it said.</p>.<p>The health body had earlier said that a decision on Bharat Biotech’s submission seeking emergency use listing (EUL) for Covaxin <a href="https://www.deccanherald.com/national/decision-on-bharat-biotechs-covaxin-eul-in-october-who-1035759.html" target="_blank">will be made in October</a>.</p>.<p>Bharat Biotech is yet to publish the results of phase 3 trials of the indigenously developed Covaxin, which is being administered as part of the country's immunisation drive against Covid-19.</p>.<p>WHO approval is crucial for allowing those who have been administered the vaccine to undertake foreign travel.</p>.<p><strong>Watch latest videos by DH here:</strong></p>
